Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Viral contamination of monoclonal antibody preparations: potential problems and possible solutions.

× No keyword cloud information.

44 in total

1. Investigations of the use of beta-propiolactone in virus inactivation.

Authors: G A LOGRIPPO
Journal: Ann N Y Acad Sci Date: 1960-01-13 Impact factor: 5.691

2. Antigenicity of beta-propiolactone-inactivated virus vaccines.

Authors: G A LOGRIPPO; F W HARTMAN
Journal: J Immunol Date: 1955-08 Impact factor: 5.422

Review 3. Is rodent virus contamination of monoclonal antibody preparations for use in human therapy a hazard?

Authors: P Carthew
Journal: J Gen Virol Date: 1986-06 Impact factor: 3.891

4. Case for concluding that heat-treated, licensed anti-haemophilic factor is free from HTLV-III.

Authors: J C Petricciani; J S McDougal; B L Evatt
Journal: Lancet Date: 1985-10-19 Impact factor: 79.321

5. beta-propiolactone/ultraviolet irradiation: a review of its effectiveness for inactivation of viruses in blood derivatives.

Authors: A M Prince; W Stephan; B Brotman
Journal: Rev Infect Dis Date: 1983 Jan-Feb

6. Characterization of virus-like particles released from the hamster cell line CHO-K1 after treatment with 5-bromodeoxyuridine.

Authors: K F Manly; J F Givens; R L Taber; R F Zeigel
Journal: J Gen Virol Date: 1978-06 Impact factor: 3.891

7. A pasteurized antithrombin III concentrate for clinical use.

Authors: J K Smith; L Winkelman; D R Evans; M E Haddon; G Sims
Journal: Vox Sang Date: 1985 Impact factor: 2.144

8. Effect of various treatments of gamma-globulin (IgG) for achieving intravenous tolerance on the capacity to interact with human monocyte Fc receptors. A comparative study.

Authors: T W Jungi; M Santer; P G Lerch; S Barandun
Journal: Vox Sang Date: 1986 Impact factor: 2.144

9. Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate.

Authors: A M Prince; B Horowitz; B Brotman
Journal: Lancet Date: 1986-03-29 Impact factor: 79.321

10. Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentrates.

Authors: C M Heldebrant; E D Gomperts; C K Kasper; J S McDougal; A E Friedman; D S Hwang; E Muchmore; S Jordan; R Miller; E Sergis-Davenport
Journal: Transfusion Date: 1985 Nov-Dec Impact factor: 3.157

1 in total

1. A simple and rapid reverse transcriptase assay for the detection of retroviruses in cell cultures.

Authors: H Kuno; H Ikeda; M Takeuchi; T Yoshida
Journal: Cytotechnology Date: 1999-05 Impact factor: 2.058

1 in total